AWM
IMCR icon

Avior Wealth Management’s Immunocore IMCR Stock Holding History

Avior Wealth Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6
Closed -$186 – 2509
2024
Q3 		$186 Hold
6
– – ﹤0.01% 2224
2024
Q2 		$203 Sell
6
-391
-98% -$19.9K ﹤0.01% 2180
2024
Q1 		$25.8K Buy
+397
New +$27.2K ﹤0.01% 1494

Other funds holding IMCR

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Avior Wealth Management's IMCR Position: Q4 2024 in Review

Avior Wealth Management sold out of Immunocore (IMCR) in Q4 2024, closing a stake of 6 shares — an estimated $186 sold.

Avior Wealth Management first reported a position in IMCR in Q1 2024 and held it in 3 quarters. The position peaked at $25.8K in Q1 2024. 115 funds tracked by Wall St. Rank hold IMCR as of Q4 2024.

  • Avior Wealth Management reported no remaining Immunocore position as of Q4 2024 after selling out during the quarter.
  • Avior Wealth Management sold 6 Immunocore shares in Q4 2024, an estimated $186.
  • Avior Wealth Management first reported a position in Immunocore in Q1 2024 and held it in 3 quarters.
  • Avior Wealth Management's Immunocore position peaked at $25.8K in Q1 2024.
  • 115 funds tracked by Wall St. Rank held Immunocore as of Q4 2024.

Based on Avior Wealth Management's 13F filing for Q4 2024, filed 17 Jan 2025.